Hemorrhagic cystitis: A retrospective single-center survey

Clinical Transplantation

Volumn 21, Issue 5, 2007, Pages 659-667

  Hassan, Zuzana ^a   Remberger, Mats ^a   Svenberg, Petter ^a   Elbander, Maria ^a   Omazic, Brigitta ^a   Mattsson, Jonas ^a   Conrad, Réka ^a   Svahn, Britt Marie ^a   Ahlgren, Anders ^a   Sairafi, Darius ^a   Aschan, Johan ^a   Le Blanc, Katarina ^a   Barkholt, Lisbeth ^a   Ringdén, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute graft versus host disease; Hemorrhagic cystitis; Risk factors; Stem cell transplantation

Indexed keywords

ANALGESIC AGENT; BUSULFAN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOSTATIC AGENT; ESTROGEN; FLUDARABINE; FORMALDEHYDE; MESNA; METHOTREXATE; MISOPROSTOL; PROSTAGLANDIN; SUCRALFATE; THROMBOCYTE CONCENTRATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; FEMALE; FLUID INTAKE; HEMATOLOGIC MALIGNANCY; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; HYDRONEPHROSIS; INFANT; IRRADIATION; MALE; MENSTRUATION DISORDER; MONOTHERAPY; MYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SURGICAL MORTALITY; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CYSTITIS; FEMALE; GRAFT VS HOST DISEASE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548612849     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00705.x     Document Type: Article

References (42)

1. Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999: 23: 35.
2. Childs R, Sanchez C, Engler H et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998: 22: 889.
3. Yang CC, Hurd DD, Case LD, A ssimos DG. Hemorrhagic cystitis in bone marrow transplantation. Urology 1994: 44: 322.
4. El-Zimaity M, Saliba R, Chan K et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: Donor type matters. Blood 2004: 103: 4674.
5. Tsuboi K, Kishi K, Ohmachi K et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003: 32: 903.
6. Vose JM, Reed EC, Pippert GC et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: A randomized trial. J Clin Oncol 1993: 11: 1306.
7. Atkinson K, Biggs JC, Golovsky D et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant 1991: 7: 351.
8. Ringden O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 1994: 83: 2723.
9. Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: An association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994: 13: 533.
10. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991: 9: 2016.
11. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: Incidence, clinical course, and outcome. J Clin Oncol 1989: 7: 194.
12. Leung AY, Mak R, Lie AK et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant 2002: 29: 509.
13. Ost L, Lonnqvist B, Eriksson L, Ljungman P, Ringden O. Hemorrhagic cystitis-a manifestation of graft versus host disease? Bone Marrow Transplant 1987: 2: 19.
14. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001: 98: 1971.
15. Held TK, Biel SS, Nitsche A et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000: 26: 347.
16. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995: 13: 1103.
17. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986: 315: 230.
18. La Rosa AM, Champlin RE, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001: 32: 871.
19. Murphy GF, Wood DP Jr, McRoberts JW, Henslee-Downey PJ. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993: 149: 565.
20. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 1989: 4: 533.
21. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993: 56: 875.
22. Giraud G, Bogdanovic G, Priftakis P et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006: 91: 401.
23. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974: 18: 295.
24. Svahn BM, Ringden O, Remberger M. Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2005: 36: 511.
25. NCI. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). In; 2003.
26. Fine J, Gray R. Proportional hazard model for the sub-distribution of competing risks. J Am Stat Assoc 1999: 94: 496.
27. Cesaro S, Brugiolo A, Faraci M et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: A survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003: 32: 925.
28. Paulin T, Ringden O, Lonnqvist B. Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 1985: 39: 377.
29. Paulin T, Ringden O, Nilsson B, Lonnqvist B, Gahrton G. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987: 43: 393.
30. Erard V, Kim HW, Corey L et al. BK DNA viral load in plasma: Evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005: 106: 1130.
31. Gorczynska E, Turkiewicz D, Rybka K et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005: 11: 797.
32. Kondo M, Kojima S, Kato K, Matsuyama T. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 1998: 22: 995.
33. Hassan M, Ljungman P, Ringden O et al. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: Time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant 2000: 25: 915.
34. Remberger M, Svahn BM, Mattsson J, Ringden O. Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation 2004: 78: 122.
35. Ruutu T, Ruutu M, Volin L, Leskinen R. Severe cystitis as a manifestation of chronic graft-versus-host disease after bone marrow transplantation. Br J Urol 1988: 62: 612.
36. Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol 2004: 54: 469.
37. Morais MM, Belarmino-Filho JN, Brito GA, Ribeiro RA. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna. Braz J Med Biol Res 1999: 32: 1211.
38. Palandri F, Bonifazi F, Rossi C et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005: 35: 529.
39. Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005: 65: 649.
40. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004: 363: 1439.
41. Ringden O, Uzunel M, Rasmusson I et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006: 81: 1390.
42. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007.